Retail Clinics

  • Pharmacist-patient relationships improve health, lower costs of care, UNC-Kerr study reveals

    RALEIGH, N.C. A healthy relationship with a community pharmacist can improve health outcomes for patients and save money, a new collaborative study from North Carolina-based Kerr Drug and the University of North Carolina revealed.

    Those benefits stem from direct interventions in patient therapy by pharmacists, coupled with a coordinated approach to the patient’s treatment regimen by his or her pharmacist and doctor, according to Kerr.

  • Nestle teams up with Cleveland Clinic for collaborative study

    GLENDALE, Calif. Nestle announced Thursday its donation to Cleveland Clinic's Lerner Research Institute to fund a collaborative study focused on examining the effects of a diet rich in whole grains on body composition and energy metabolism.

  • Reaching out to new CMS administrator Berwick, NACDS highlights pro-patient, pro-pharmacy goals

    ALEXANDRIA, Va. The National Association of Chain Drug Stores is moving quickly to establish a working relationship with newly installed Medicare and Medicaid chief Donald Berwick.

    NACDS on Wednesday sent a letter to Berwick, who was tapped by President Obama to serve as the new administrator of the Centers for Medicare & Medicaid Services. NACDS president and CEO Steve Anderson urged continued collaboration with CMS on issues related to pharmacy that he said are vital to quality health care and cost reduction.

  • Local Blue Cross Blue Shield offers ER alternatives to members

    RICHMOND, Va. Looking to help inform consumers on how to best access emergency room alternatives and receive the same medical care with less out-of-pocket cost, Anthem Blue Cross and Blue Shield in Virginia has announced the creation of a Google Map that identifies all of the ER alternatives available to members throughout the state.

  • FDA approves additional strengths of Actavis' generic Wellbutrin SR

    MORRISTOWN, N.J. Actavis has received regulatory approval from the Food and Drug Administration for a generic antidepressant, the drug maker announced Wednesday.

    Actavis said it immediately will begin distributing its bupropion HCl extended-release (SR) tablets in 100-mg and 200-mg strengths. The drug is the generic equivalent of GlaxoSmithKline's Wellbutrin SR. Actavis already has marketed generic Wellbutrin SR in the 150-mg strength. The drug maker received approval in March 2008.

  • Health IT vital to medication therapy, NACDS tells congressional panel

    ALEXANDRIA, Va. In a new plea to Congress, the chain pharmacy industry renewed its support for the rapid nationwide adoption of health information technology as a major tool in the nation’s drive to improve patient compliance with medication therapy.

     

  • Carmex enters skin care category

    MILWAUKEE Carma Labs, the maker of Carmex lip balm products, is expanding beyond lip balm for the first time with the launch of its new skin care product line: Carmex healing lotion and Carmex healing cream.

    Carmex skin care products will be available exclusively at all Walgreens locations in the United States and Walgreens.com beginning in August, and through Drugstore.com beginning in September.

  • PhRMA: 313 mental disorder treatments are in development

    WASHINGTON More than 300 medications for treating mental disorders are in development, according to a new report by a pharmaceutical industry lobbying group.

     

  • Prestige Brands revamps its Chloraseptic line

    IRVINGTON, N.Y. Prestige Brands recently announced the introduction of a revamped line of Chloraseptic sore throat lozenges and Chloraseptic throat spray.

    In addition to soothing sore throat pain, the lozenges help cool nasal passages and ease coughs, the company stated. The new lozenge includes cherry, citrus, honey lemon and green tea flavors.

     

    The Chloraseptic lozenge line is available in 15- and 18-count packs with a suggested retail price of $3.99.

     

     

  • FDA: Stolen inhalers being sold at pharmacies

    SILVER SPRING, Md. Some stolen inhalers for patients with asthma and chronic obstructive pulmonary disease have turned up in pharmacies, the Food and Drug Administration warned Friday.

    Two lots of GlaxoSmithKline’s Advair Diskus (fluticasone propionate and salmeterol) were stolen from a warehouse near Richmond, Va., last August, with lot numbers 9ZP2255 – NDC 0173-0696-00 and 9ZP3325 – NDC 0173-0697-00. The inhalers recently found were the first from the stolen lots to turn up in commerce, the FDA said.

     

X
This ad will auto-close in 10 seconds